| Report ID | Date of report | Patient age | Patient gender |
| 30057 | Jan, 22, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Mestinon | pyridostigmine bromide |
| Name |
Agitation |
Anger |
Asthenia |
Choking |
Condition Aggravated |
Coordination Abnormal |
Dysarthria |
Fatigue |
Feeling Abnormal |
Headache |
Hypersensitivity |
Hypoventilation |
Incorrect Dose Administered |
Influenza Like Illness |
Irritability |
Lacrimation Increased |
Malaise |
Muscle Twitching |
Myasthenia Gravis |
Nausea |
Rhinorrhoea |
Salivary Hypersecretion |
Somnolence |
Therapeutic Response Unexpected With Drug Substitution |
Vision Blurred |
Results from eHealthMe : 991 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Agitation | 8 (0.81%) |
Anger | 1 (0.10%) |
Asthenia | 53 (5.35%) |
Choking | 3 (0.30%) |
Condition Aggravated | 78 (7.87%) |
Coordination Abnormal | 2 (0.20%) |
Dysarthria | 24 (2.42%) |
Fatigue | 40 (4.04%) |
Feeling Abnormal | 9 (0.91%) |
Headache | 12 (1.21%) |
Hypersensitivity | 11 (1.11%) |
Hypoventilation | 4 (0.40%) |
Incorrect Dose Administered | 1 (0.10%) |
Influenza Like Illness | 6 (0.61%) |
Irritability | 1 (0.10%) |
Lacrimation Increased | 3 (0.30%) |
Malaise | 28 (2.83%) |
Muscle Twitching | 4 (0.40%) |
Myasthenia Gravis | 124 (12.51%) |
Nausea | 41 (4.14%) |
Rhinorrhoea | 2 (0.20%) |
Salivary Hypersecretion | 3 (0.30%) |
Somnolence | 9 (0.91%) |
Therapeutic Response Unexpected With Drug Substitution | 4 (0.40%) |
Vision Blurred | 8 (0.81%) |
Top 3 (total: 994. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Prednisone | 151 (2.51%) |
Prednisolone | 128 (2.13%) |
Aspirin | 80 (1.33%) |
Death reported: 10 (1.01% of total reports)
| Name | Count (% of total reports) |
Myasthenia Gravis | 124 (12.51%) |
Condition Aggravated | 78 (7.87%) |
Dysphagia | 59 (5.95%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
